According to the MHRA-approved product information, these include: Nausea (very common, affecting more than 1 in 10 patients) Vomiting and diarrhoea (common, affecting up to 1 in 10 patients) Abdominal pain and constipation (common) Decreased appetite (common) These gastrointestinal symptoms typically occur during the initial weeks of treatment or following dose escalation and often diminish over time as the body adjusts to the medication
Although it is primarily prescribed to support metabolic control and weight management, these hormonal effects can also influence digestion, circulation, and certain cardiovascular responses as the body adjusts to treatment
Handle using appropriate laboratory procedures
The conjugation of ACPs to polymers such as polyethylene glycol has also been found to improve dynamics/pharmacokinetics by boosting penetration into desired cancer cells and allowing for additional circulation time (174)
Our focus is not just on helping you lose weight but on helping you keep it off
For patients with metabolic disorders, L-Carnitine supplementation can be critical
